Involvement of the lectin pathway of complement activation in antimicrobial immune defense during experimental septic peritonitis

Infection and Immunity

Volumn 72, Issue 9, 2004, Pages 5247-5252

  Windbichler, Michaela ^a,b   Echtenacher, Bernd ^a   Hehlgans, Thomas ^a   Jensenius, Jens C ^c   Schwaeble, Wilhelm ^a,b   Männel, Daniela N ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ANTIBODY; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C2; LECTIN; MANNAN BINDING LECTIN; MANNAN BINDING LECTIN A; MANNAN BINDING LECTIN C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL PERITONITIS; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT SYSTEM; CONTROLLED STUDY; HOST RESISTANCE; MICROBIAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SURVIVAL;

ANIMALS; BACTERIAL INFECTIONS; CECUM; COLONY COUNT, MICROBIAL; COMPLEMENT ACTIVATION; COMPLEMENT C1Q; COMPLEMENT C2; COMPLEMENT FACTOR B; COMPLEMENT PATHWAY, ALTERNATIVE; LIGATION; LIVER; MANNOSE-BINDING LECTIN; MICE; PERITONITIS; PUNCTURES; SEPSIS; SPLEEN;

EID: 4544235126     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.9.5247-5252.2004     Document Type: Article

References (53)

1. Ambrus, G., P. Gal, M. Kojiraa, K. Szilagyi, J. Balczer, J. Antal, L. Graf, A. Laich, B. E. Moffatt, W. Schwaeble, R. B. Sim, and P. Zavodszky. 2003. Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments. J. Immunol. 170:1374-1382.
2. Botto, M., C. Dell'Agnola, A. E. Bygrave, E. M. Thompson, H. T. Cook, F. Petty, M. Loos, P. P. Pandolfi, and M. J Walport. 1998. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19:56-59.
3. Brown, J. S., T. Hussell, S. M. Gilliland, D. W. Holden, J. C. Paton, M. R. Ehrenstein, M. J. Walport, and M. Botto. 2002. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc. Natl. Acad. Sci. USA 99:16969-16974.
4. Celik, I., C. Stover, M. Botto, S. Thiel, S. Tzima, D. Kunkel, M. Walport, W. Lorenz, and W. Schwaeble. 2001. Role of the classical pathway of complement activation in experimentally induced polymicrobial peritonitis. Infect. Immun. 69:7304-7309.
5. Chirgwin, J., A. Przybyla, R. MacDonald, and W. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 18:5294.
6. Collard, C. D., A. Vakeva, M. A. Morrissey, A. Agah, S. A. Rollins, W. R. Reenstra, J. A. Buras, S. Meri, and G. L. Stahl. 2000. Complement activation after oxidative stress: role of the lectin complement pathway. Am. J. Pathol. 156:1549-1556.
7. Dodds, A. W. 1993. Small-scale preparation of complement components C3 and C4. Methods Enzymol. 223:46-61.
8. Echtenacher, B., W. Falk, D. N. Mannel, and P. H. Krammer. 1990. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J. Immunol. 145:3762-3766.
9. Echtenacher, B., and D. N. Männel. 2002. Requirement of TNF and TNF receptor type 2 for LPS-induced protection from lethal septic peritonitis. J. Endotoxin Res. 8:365-369.
10. Echtenacher, B., D. N. Männel, and L. Hültner. 1996. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381:75-77.
11. Echtenacher, B., R. Urbaschek, K. Weigl, M. A. Freudenberg, and D. N. Männel. 2003. Treatment of experimental sepsis-induced immunoparalysis with TNF. Immunobiology 208:381-389.
12. Echtenacher, B., K. Weigl, N. Lehn, and D. N. Männel. 2001. Tumor necrosis factor-dependent adhesions as a major protective mechanism early in septic peritonitis in mice. Infect. Immun. 69:3550-3555.
13. Ezekowitz, R. A. B., L. E. Day, and G. A. Herman. 1988. A human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins. J. Exp. Med. 167:1034-1046.
14. Garred, P., J. J. Strom, L. Quist, E. Taaning, and H. O. Madsen. 2003. Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J. Infect. Dis. 188:1394-1403.
15. Ghiran, I., S. F. Barbashov, L. B. Klickstein, S. W. Tas, J. C. Jensenius, and A. Nicholson-Weller. 2000. Complement receptor 1/CD35 is a receptor for mannan-binding lectin. J. Exp. Med. 192:1797-1808.
16. Gunning, P., P. Ponte, H. Okayama, J. Engel, H. Blau, and L. Kedes. 1983. Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol. Cell. Biol. 3:787-795.
17. Hansen, S., and U. Holmskov. 1998. Structural aspects of collectins and receptors for collectins. Immunobiology 199:165-189.
18. Hansen, S., S. Thiel, A. Willis, U. Holmskov, and J. C. Jensenius. 2000. Purification and characterization of two mannan-binding lectins from mouse serum. J. Immunol. 164:2610-2618.
19. Holmskov, U., S. Thiel, and J. C. Jensenius. 2003. Collections and ficolins: humoral lectins of the innate immune defense. Annu. Rev. Immunol. 21:547-578.
20. Holmskov, U. L. 2000. Collectins and collectin receptors in innate immunity. APMIS Suppl. 100:1-59.
21. Ikeda, K., T. Sannoh, N. Kawasaki, T. Kawasaki, and I. Yamashina. 1987. Serum lectin with known structure activates complement through the classical pathway. J. Biol. Chem. 262:7451-7454.
22. Kuhlman, M., K. Joiner, and R. A. Ezekowitz. 1989. The human mannose-binding protein functions as an opsonin. J. Exp. Med. 169:1733-1745.
23. Le, Y., S. H. Lee, O. L. Kon, and J. Lu. 1998. Human L-ficolin: plasma levels, sugar specificity, and assignment of its lectin activity to the fibrinogen-like (FBG) domain. FEES Lett. 425:367-370.
24. Liu, H., L. Jensen, S. Hansen, S. V. Petersen, K. Takahashi, A. B. Ezekowitz, F. D. Hansen, J. C. Jensenius, and S. Thiel. 2001. Characterization and quantification of mouse mannan-binding lectins (MBL-A and MBL-C) and study of acute phase responses. Scand. J. Immunol. 53:489-497.
25. Lu, J. H., S. Thiel, H. Wiedemann, R. Timpl, and K. B. Reid. 1990. Binding of the pentamer/hexamer forms of mannan-binding protein to zymosan activates the proenzyme C1r2C1s2 complex, of the classical pathway of complement, without involvement of C1q. J. Immunol. 144:2287-2294.
26. Lynch, N. J., S. Roscher, T. Hartung, S. Morath, M. Matsushita, D. N. Männel, M. Kuraya, T. Fujita, and W. J. Schwaeble. 2004. L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of gram-positive bacteria, and activates the lectin pathway of complement. J. Immunol. 172:1198-1202.
27. Madsen, H. O., P. Garred, S. Thiel, J. A. Kurtzhals, L. U. Lamm, L. P. Ryder, and A. Svejgaard. 1995. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J. Immunol. 155:3013-3020.
28. Matsushita, M., and T. Fujita. 1992. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J. Exp. Med. 176:1497-1502.
29. Matsushita, M., and H. Okada. 1986. Alternative complement pathway activation by C4b deposited during classical pathway activation. J. Immunol. 136:2994-2998.
30. Matsushita, M., Y. Endo, and T. Fujita. 2000. Cutting edge: complement-activating complex of ficolin and mannose-binding lectin-associated serine protease. J. Immunol. 164:2281-2284.
31. Matsushita, M., M. Kuraya, N. Hamasaki, M. Tsujimura, H. Shiraki, and T. Fujita. 2002. Activation of the lectin complement pathway by H-ficolin (Hakata antigen). J. Immunol. 168:3502-3506.
32. Maurer, M., B. Echtenacher, L. Haltner, G. Kollias, D. N. Mannel, K. E. Langley, and S. J. Galli. 1998. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J. Exp. Med. 188:2343-2348.
33. Naito, H., A. Ikeda, K. Hasegawa, S. Oka, K. Uemura, N. Kawasaki, and T. Kawasaki. 1999. Characterization of human serum mannan-binding protein promoter. J. Biochem. 126:1004-1012.
34. Ogden, C. A., A. deCathelineau, P. R. Hoffmann, D. Bratton, B. Ghebrehiwet, V. A. Fadok, and P. M. Henson. 2001. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194:781-795.
35. Petersen, S. V., S. Thiel, L. Jensen, R. Steffensen, and J. C. Jensenius. 2001. An assay for the mannan-binding lectin pathway of complement activation. J. Immunol. Methods 257:107-116.
36. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y.
37. Sastry, K., K. Zahedi, J. M. Leilas, A. S. Whitehead, and R. A. Ezekowitz. 1991. Molecular characterization of the mouse mannose-binding proteins. The mannose-binding protein A but not C is an acute phase reactant. J. Immunol. 147:692-697.
38. Schwaeble, W. J., and K. B. Reid. 1999. Does properdin crosslink the cellular and the humoral immune response? Immunol. Today 20:17-21.
39. Suankratay, C., X. H. Zhang, Y. Zhang, T. F. Lint, and H. Gewurz. 1998. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway. J. Immunol. 160:3006-3013.
40. Super, M., S. Thiel, J. Lu, R. J. Levinsky, and M. W. Turner. 1989. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet ii:1236-1239.
41. Takahashi, K., J. Gordon, H. Liu, K. N. Sastry, J. E. Epstein, M. Motwani, I. Laursen, S. Thiel, J. C. Jensenius, M. Carroll, and R. A. Ezekowitz. 2002. Lack of mannose-binding lectin-A enhances survival in a mouse model of acute septic peritonitis. Microbes Infect. 4:773-784.
42. Taylor, P. R., J. T. Nash, E. Theodoridis, A. E. Bygrave, M. J. Walport, and M. Botto. 1998. A targeted disruption of the murine complement factor B gene resulting in loss of expression of three genes in close proximity, factor B, C2, and D17H6S45. J. Biol. Chem. 273:1699-1704.
43. Thiel, S., U. Holmskov, L. Hviid, S. B. Laursen, and J. C. Jensenius. 1992. The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin. Exp. Immunol. 90:31-35.
44. Thiel, S., T. Vorup-Jensen, C. M. Stover, W. Schwaeble, S. B. Laursen, K. Poulsen, A. C. Willis, P. Eggleton, S. Hansen, U. Holmskov, K. B. Reid, and J. C. Jensenius. 1997. A second serine protease associated with mannan-binding lectin that activates complement. Nature 386:506-510.
45. Thiel, S., S. V. Petersen, T. Vorup-Jensen, M. Matsushita, T. Fujita, C. M. Stover, W. J. Schwaeble, and J. C. Jensenius. 2000. Interaction of C1q and mannan-binding lectin (MBL) with C1r, C1s, MBL-associated serine proteases 1 and 2, and the MBL-associated protein MAp19. J. Immunol. 165:878-887.
46. Uemura, K., M. Saka, T. Nakagawa, N. Kawasaki, S. Thiel, J. C. Jensenius, and T. Kawasaki. 2002. L-MBP is expressed in epithelial cells of mouse small intestine. J. Immunol. 169:6945-6950.
47. Urbaschek, B., B. Differ, K. P. Becker, and R. Urbaschek. 1984. Protective effects and role of endotoxin in experimental septicemia. Circ. Shock 14:209-222.
48. Vandivier, R. W, C. A. Ogden, V. A. Fadok, P. R. Hoffmann, K. K. Brown, M. Botto, M. J. Walport, J. H. Fisher, P. M. Henson, and K. E. Greene. 2002. Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro; calreticulin and CD91 as a common collectin receptor complex. J. Immunol. 169:3978-3986.
49. Volk, H. D., P. Reinke, D. Krausch, H. Zuckermann, K. Asadullah, J. M. Muller, W. D. Docke, and W. J. Kox. 1996. Monocyte deactivation-rationale for a new therapeutic strategy in sepsis. Intensive Care Med. 22(Suppl 4):S474-S481.
50. Vorup-Jensen, T., S. V. Petersen, A. G. Hansen, K. Poulsen, W. Schwaeble, R. B. Sim, K. B. M. Reid, S. J. Davis, S. Thiel, and J. C. Jensenius. 2000. Distinct pathways of mannan-binding lectin (MBL)- and C1-complex auto-activation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2. J. Immunol. 165:2093-2100.
51. Wagner, S., N. J. Lynch, W. Walter, W. J. Schwaeble, and M. Loos. 2003. Differential expression of the murine mannose-binding lectins A and C in lymphoid and nonlymphoid organs and tissues. J. Immunol. 170:1462-1465.
52. Werling, D., and T. W. Jungi. 2003. TOLL-like receptors linking innate and adaptive immune response. Vet. Immunol. Immunopathol. 91:1-12.
53. Wichterman, K. A., A. E. Baue, and I. H. Chaudry. 1980. Sepsis and septic shock-a review of laboratory models and a proposal. J. Surg. Res. 29:189-201.